More on iRON
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $68.00 |
|
|||
| Open | $68.01 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $70.50 | ||||
| Day Low | $67.01 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 335,623 | ||||
- Disc Medicine (IRON) Reiterated at Buy by Stifel
- Disc Medicine reports positive anemia trial results at ASCO meeting
- Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
- Disc Medicine launches expanded access program for bitopertin
- Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients
- Disc Medicine (IRON) PT Raised to $80 at Morgan Stanley
- Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress
- Disc Medicine to Participate in Upcoming Investor Conferences
- Disc Medicine (IRON) Misses Q1 EPS by 1c
- Form 10-Q Disc Medicine, Inc. For: Mar 31
Entities mentioned with IRON
- FDA | View Related Stories »
- Atlas Venture | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Stifel | View Related Stories »
- Show More...
